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Abstract
Background: While driving impaired is a well-recognized risk factor for motor vehicle (MV) crash, recent trends in
recreational drug use and abuse may pose increased threats to occupant safety. This study examines mechanisms
through which drug and/or alcohol combinations contribute to fatal MV crash.
Methods: The Fatality Analysis Reporting System (FARS) for 2008–2013 was used to examine drugs, alcohol, driver
restraint use, driver violations/errors and other behaviors of drivers of passenger vehicles who were tested for both
alcohol and drugs (n = 79,932). Statistical analysis was based on Chi-square tests and multivariable logistic regression.
Associations of restraint use and other outcomes with alcohol and drug use were measured by estimated odds ratios
(ORs) and 95 % confidence intervals (95 % CIs).
Results: More than half (54.8 %) of the study population were positive for drugs or alcohol at the time of crash.
Approximately half of drivers were belted, but this varied from 67.1 % (unimpaired) to 33.0 % (drugs plus alcohol).
Compared to the unimpaired, the odds of a driver being unbelted varied: alcohol and cannabis (OR 3.70, 95 % CI
3.44–3.97), alcohol only (3.50,3.36–3.65), stimulants (2.13,1.91–2.38), depressants (2.09,1.89–2.31), narcotics (1.84,1.67–2.02)
and cannabis only (1.55,1.43–1.67). Compared to belted drivers, unbelted drivers were over 4 times more likely to die.
Driving violations varied across drug/drug alcohol combinations. Speed-related violations were higher for drivers positive
for stimulants, alcohol, cannabis, and cannabis plus alcohol, with a more than two fold increase for alcohol and cannabis
(2.36, 2.05, 2.71).
Conclusions: Mechanisms through which drugs, alcohol and substance combinations produce increased risks to
occupant safety include lowered restraint use and increases in risky driving behaviors, including speeding, lane,
passing, turning and signal/sign violations.
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Background
The contribution of alcohol to motor vehicle crash
risk has long been recognized (Maull et al. 1984;
Soderstrom et al. 1993; Quinlan et al. 2005), but the
mechanisms through which various drugs and drug
combinations contribute to serious MV crash are less
well understood. The prevalence of non-alcohol drug
use by drivers has increased in the last few decades
with marijuana becoming the leading drug detected in
fatal crashes (Brady and Li 2014). With the recent
trends in substance use and abuse nationally (SAMHSA
2014) and the legalization of recreational use of
marijuana in several states, it has become more im-
perative to understand the effect of drugs on driving
performance.
In laboratory and simulated driving tests, the effect
of marijuana has been shown to differ between individ-
uals, with marijuana use having a well-acknowledged
effect on driving ability, including latency in reaction
time and failure to keep in the proper lane (Kurzthaler
et al. 1999; Ramaekers et al. 2000). The effect of stimu-
lants on driving abilities varies among types of users
with several studies demonstrating that low-dose thera-
peutic use of stimulants for attention deficit hyperactiv-
ity disorder patients can have a positive effect on
driving abilities (Cox et al. 2000; Barkley and Cox 2007).
In simulated driving experiments, high doses of stimu-
lants have been associated with driving impairments, in-
cluding increased failure to stop and signal violations
(Silber et al. 2005). While other studies in Europe and
Australia also suggest that the risk of causing motor ve-
hicle crashes may differ from drug to drug (Mura et al.
2003; Drummer et al. 2004; Giovanardi et al. 2005), the
mechanisms through which this occurs have not been
well elucidated.
While experimental evidence obtained through simu-
lated driving and road tests have shown that substances
can have significant effects on driving performance, less
is known from epidemiological studies that examine
actual crash data (Gates et al. 2013; Reguly et al. 2014;
Dubois et al. 2015). Recent studies have documented
the increase in fatal motor vehicle crashes associated
with drugged driving especially when combined with
alcohol (Romano and Pollini 2013; Li et al. 2013), but
these studies did not examine the distribution of driv-
ing errors and driving violations contributing to the
fatality or how this might vary across drugs.
This study aims to examine the mechanisms through
which this occurs, including the relationship between
fatal crashes and driver characteristics, driver behavior
and driving violations/errors by drug/drug category.
Drug combinations are examined with and without the
presence of alcohol for their association with restraint
use and driving violations.
Methods
Data source
Data were obtained from the Fatality Analysis Report-
ing System (FARS) for calendar years 2008–2013. FARS
is a census of all traffic fatalities on U.S. roadways. It
contains person, vehicle and crash level variables. FARS
captures up to three drug results for each driver. Drug
detection was by means of a blood test, urine test or
both. Driver characteristics (age, gender, alcohol and
drug tests and violations charged), vehicle characteris-
tics (body type), and crash characteristics (number of
vehicles involved, crash-related factors, manner of collision,
weekend/weekday and time of the crash) were analyzed.
The data used in the analyses in this paper have been de-
termined not human subjects research. They are all dei-
dentified and publicly available and downloadable from
National Highway Traffic Safety Administration (NHTSA)
http://www.nhtsa.gov/FARS.
Study population
The study population was comprised of 79,932 of drivers
aged 15 years and older who were tested for both alco-
hol and drugs after being involved in a fatal crash of a
passenger vehicle. Drivers of large trucks, motor homes,
motorcycles, buses, ATVs, farm equipment, large limou-
sines, and vehicles of unknown type are excluded from
analysis. Drivers with missing drug status and violation
status were also excluded (Fig. 1).
Variable definitions
Driver characteristics
Demographics Age was categorized as 15–17, 18–19,
20–24, 25–44, 45–64 and 65 years and older. Gender
was categorized as male or female as provided in FARS.
Race was only coded for fatalities in FARS and was not
examined in this study.
Restraint use Restraint use was dichotomized: 1) not
belted; and 2) belted. Shoulder belt, lap belt, shoulder
and lap belt were categorized as belted.
Injury severity Two variables were created to reflect
injury severity. A dichotomous variable coded mortal-
ity outcome as lived or died. A second variable was
categorized as: 1) not injured; 2) non-incapacitating injury;
3) incapacitating injury; and 4) fatal injury.
Number of occupants Number of occupants in the ve-
hicle was categorized into three groups: 1) driver only;
2) driver and one other passenger; and 3) driver and two
or more other passengers.
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Alcohol and drug use FARS recorded up to three drug
test results for each driver. In this study, drug/drug
category was categorized into five groups: 1) narcotics;
2) depressants; 3) stimulants; 4) cannabinoid; and 5) other
(phencyclidine, anabolic steroid, inhalants, and drugged,
unknown type) as provided in FARS. Alcohol-involved
crash was analyzed as a dichotomous variable with the
driver considered positive if the blood alcohol concentra-
tion was 0.01 or higher or if police reported the driver was
drinking. Among drivers considered positive for alcohol,
91.4 % had a BAC level higher than 0.05 and 84.9 % had a
BAC Level higher than 0.08. Drivers with more than one
type of drug/drug category or alcohol were included in the
category multiple drugs/alcohol.
Driver violations charged/driver error
Crash related factors and driving violations were catego-
rized as follows: sign/signal, turning, passing, reckless-
driving, speed, lane or any moving violation.
Sign/signal violations Violations involving red light
running or other traffic signs or signals were included as
a sign violation.
Turning violations Violations involving improper turn,
turning from the wrong lane, failure to signal intention or
turn, or failure to yield were included as a turning violation.
Passing violations Violations involving wrong side,
passing or following too closely were included as a pass-
ing violation.
Reckless-driving violations Violations involving willful
and non-willful reckless, careless or hit-and-run offenses
were included as a reckless violation.
Speed-related violation Violations involving high
speed-related offenses were categorized as a speed vio-
lation. Driving too slow was not included as a speed
violation.
Drivers alive prior to crash
N=220,744
Total number of drivers 
N=287,695
Drivers in passenger vehicles
N=223,142
Drivers age 15 and older
N=220,758
Drivers of non-passenger vehicles or 
missing vehicle type
N=64,553
Drivers age 14 and younger
N=2,384
Drivers died prior to crash
N=14




Drivers with missing violation charges 
and driving errors
N=23
Drivers not tested/missing blood alcohol 
concentration and drug test results
N=140,789
Fig. 1 Study population
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Lane violations Violations involving improper use or
erratic change of lanes were included as a lane violation
as defined in FARS (FARS 2014).
Any moving violations Violations involving a sign, turn,
passing, reckless, speed-related or lane violations were
categorized as presence of any moving violation.
Nonmoving violations Violations involving validity of
driver license, vehicle insurance or vehicle registrations
were included as a non-moving violation.
Crash characteristics
Number of vehicles in crash Number of vehicles in the
crash was categorized as: 1) single vehicle; 2) two vehicle
or 3) multiple vehicles.
Manner of collision Manner of collision described the
orientation of two motor vehicles in-transport and in-
volved in a collision. Manner of collision was categorized
as follows: not a collision with motor vehicle in trans-
port, head-on, rear-end, angle, sideswipe, or other (end-
swipe and others).
Time of crash (Day or Night) Time of day was catego-
rized as daytime (6:00 am to 5:59 pm) and nighttime
(6:00 pm to 5:59 am).
Ejection Ejection was categorized as: 1) ejected; or 2) not
ejected. Partially ejected was included as ejected.
Weekday/weekend Crashes occurring in the period
from Friday at 6:00 pm until Monday at 5:59 am were
categorized as a weekend crash.
Statistical analysis
Bivariable descriptive analyses were performed for driver
characteristics, moving violations and crash characteris-
tics stratified by drug/drug categories. Types of moving
violations were analyzed across drug/drug categories.
Bivariable analyses were performed using chi-square or
Fisher’s exact test. Numerical qualities were assessed for
variables to be used in multivariable logistic models. The
associations of different drug/drug categories, restraint
use and mortality were analyzed using multivariable lo-
gistic regression with odds ratios reported with 95 %
confidence intervals. Initial model selection was based
on bivariable analysis with theoretical considerations
and p ≤0.2 for variable inclusion in the model. Final
models were age and gender-adjusted but otherwise in-
cluded only variables whose odds ratios were significant
at p ≤0.05. Final multivariable models were adjusted for
age, gender, time of day, weekend, number of occu-
pants. All analyses were calculated in SAS 9.4.
Results
The study population consisted of 79,932 drivers, of which
61.1 % were aged between 25 and 64 years (Table 1). The
majority of the study population was male (71.2 %). Nearly
56 % of drivers were driving solo without a passenger
(Table 1). More than half (54.8 %) of the study population
were positive for drugs or alcohol detected at the time of
crash. Drug and alcohol use was higher in drivers aged
20–24 (23.3 %) and 24–44 (47.4 %) years. Males also
accounted for the majority of drivers using drugs (67.5 %),
alcohol (81.9 %) and both drugs and alcohol (79.5 %)
(Table 1).
Injury mortality
The majority of drivers were fatally injured (73.5 %), but
this was higher in drivers with alcohol detected (79.4 %),
(X2 = 1686.5, p <0.0001). Compared to drivers without
drugs or alcohol, the odds ratios of fatal injury were
higher for alcohol (1.99, 95 % CI: 1.90, 2.09), cannabis
and alcohol in combination (1.50, 1.39, 1.61), stimulants
(1.36, 95 % CI: 1.21, 1.53), depressants (1.35, 95 % CI:
1.20, 1.50), and narcotics (1.18, 95 % CI: 1.06, 1.31).
Restraint status
Slightly more than half of drivers were belted (51.9 %), but
this varied by drug and alcohol status ranging from 67.1 %
belted (no drugs or alcohol detected) to 33.0 % belted
(both drugs and alcohol detected) (Table 1). Belted status
varied by drug/drug categories. Unbelted drivers were
over 4 times more likely to die in the crash compared to
belted drivers (age- and gender-adjusted odds of death,
4.42, 95 % CI: 4.25, 4.60). These are notable for drivers
with both alcohol and cannabis who were 3.7 times more
likely to be unbelted and drivers on alcohol were 3.5 times
more likely to be unbelted. Drivers on depressants or
stimulants were twice as likely to be unbelted.
Manner of collision
Manner of collision differed among drugged and non-
drugged drivers, in that, drivers with alcohol and drugs
were more likely to experience rollover or a single vehicle
related-crash (Table 1). Collision type was also associated
with mortality, with rollover (OR = 3.17 95 % CI: 2.94,
3.42) and a tree-related crashes (OR = 5.34 95 % CI: 4.91,
5.81) having higher mortality compared to other collision
types examined.
Violations and driving errors by drug/drug category
The distribution of being charged with a moving viola-
tion varied across drug/drug category from 33.2 % for
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Table 1 Driver and crash characteristics by drug and alcohol use for drivers of passenger vehicles involved in a fatal motor vehicle
crash, Fatality Analysis Reporting System (FARS), 2008–2013
No drug n (%) Drugs only n (%) Alcohol only n (%) Drug + Alcohol n (%)a Total Chi square
36,115 (45.2) 12,771 (16.0) 18,986 (23.8) 12,060 (15.1) 79,932
Driver characteristics
Driver age (years) 8552.8 (<0.0001)
15–17 1764 (4.9) 411 (3.2) 273 (1.4) 247 (2.1) 2695 (3.4)
18–19 2600 (7.2) 874 (6.8) 922 (4.9) 732 (6.1) 5128 (6.4)
20–24 4287 (11.9) 1925 (15.1) 4106 (21.6) 2811 (23.3) 13,129 (16.4)
25–44 9763 (27.0) 4954 (38.8) 8815 (46.4) 5673 (47.4) 29,205 (36.5)
45–64 9806 (27.2) 3406 (26.7) 4039 (21.3) 2382 (19.8) 19,633 (24.6)
65+ 7883 (21.8) 1192 (9.3) 823 (4.3) 213 (1.8) 10,111 (12.7)
Driver gender 2446.7 (<0.0001)
Male 23,160 (64.1) 8614 (67.5) 15,550 (81.9) 9590 (79.5) 56,914 (71.2)
Female 12,951 (35.9) 4154 (32.5) 3430 (18.1) 2465 (20.4) 23,000 (28.8)
Injury severity 1686.5 (<0.0001)
Not injured 5192 (15.1) 1288 (10.5) 1246 (6.8) 754 (6.5) 8480 (11.0)
Non-incapacitating injury 2808 (8.2) 1080 (8.8) 1336 (7.3) 1067 (9.2) 6291 (8.2)
Incapacitating injury 1954 (5.7) 1153 (9.4) 1211 (6.6) 1232 (10.6) 5550 (7.2)
Fatal injury 24,497 (71.1) 8726 (71.3) 14,625 (79.4) 8606 (73.8) 56,454 (73.5)
Driver restraint use 7181.9 (<0.0001)
Belted 24,212 (67.1) 6539 (51.2) 6765 (35.6) 3976 (33.0) 41,492 (51.9)
Not belted 9616 (26.6) 1059 (40.5) 10,471 (55.2) 6878 (57.0) 32,138 (40.2)
Number of occupants 319.7 (<0.0001)
One (Driver only) 20,030 (55.5) 7340 (57.5) 10,605 (55.9) 6535 (54.2) 44,510 (55.7)
Two (Driver with one passenger) 6004 (16.6) 2329 (18.2) 2969 (15.6) 2324 (19.3) 13,626 (17.1)
Three or more 3726 (10.3) 1370 (16.5) 1762 (9.3) 1423 (17.2) 8281 (10.4)
Crash characteristics
Violation charged
Sign 2262 (6.3) 783 (6.1) 1084 (5.7) 817 (6.8) 4946 (6.2) 15.1 (0.0018)
Turning 1604 (4.4) 541 (4.2) 861 (4.5) 442 (3.7) 3448 (4.3) 16.2 (0.0011)
Passing 2073 (5.7) 1074 (8.4) 1809 (9.5) 1006 (8.3) 5962 (7.5) 302.7 (<0.0001)
Reckless driving 3826 (10.6) 2292 (18.0) 4376 (23.1) 3041 (25.2) 13,535 (16.9) 2134.1 (<0.0001)
Speed related 1491 (4.1) 673 (5.3) 1767 (9.3) 1142 (9.5) 5073 (6.4) 801.6 (<0.0001)
Lane 3308 (9.2) 1324 (10.4) 2522 (13.3) 1488 (12.4) 8642 (10.8) 254.3 (<0.0001)
Any moving violation 12,010 (33.3) 5393 (42.2) 9720 (51.2) 6182 (51.3) 33,305 (41.7) 2219.0 (<0.0001)
Number of vehicles in crash 6230.4 (<0.0001)
Single vehicle 13,014 (36.0) 5416 (42.4) 12,554 (66.1) 7916 (65.6) 38,900 (48.7)
Two vehicles 18,470 (51.2) 5922 (46.4) 5311 (28.0) 3336 (27.6) 33,039 (41.3)
Multiple vehicles 4631 (12.8) 1433 (11.2) 1121 (5.9) 808 (6.7) 7993 (10.0)
Manner of collision 6093.8 (<0.0001)
Not a collision of vehicle in transport 14,647 (40.6) 5978 (46.8) 13,334 (70.2) 8433 (69.9) 42,392 (53.0)
Rollover 2175 (6.0) 910 (7.1) 2177 (11.5) 1262 (10.5) 6524 (8.2)
Tree 2266 (6.3) 1139 (8.9) 2406 (12.7) 1629 (13.5) 7440 (9.3)
Pedestrian 2467 (6.8) 562 (4.4) 511 (2.7) 311 (2.6) 3851 (4.8)
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drivers without drug and alcohol detected to 51.4 % for
drivers with alcohol detected (Table 2).
Any moving violation and reckless driving violations
were increased significantly for all drug/drug categories
(Fig. 2a and b). Except for cannabis, increased odds were
also observed for all drug and drug categories for commit-
ting lane violations and passing violations (Fig. 2c and d).
Speed-related violations were higher for drivers positive
for stimulants, alcohol, cannabis, and cannabis plus al-
cohol (Fig. 2e). Sign violations were higher with canna-
bis, both with and without alcohol (Fig. 2f ). Turning
violations were higher with stimulants and with alcohol
(Fig. 2g).
Multivariable adjusted odds of driving errors/driving
violations are shown in Table 3. Drivers on narcotics or
depressants exhibited similar driving patterns that dif-
fered somewhat in magnitude, with both being more
likely to be cited for lane and passing violations. Drivers
positive for either stimulants or alcohol, but not both,
were more likely to be cited for speed-related crashes
and for turning violations, in addition to the lane and
passing violations seen with narcotics and depressants.
Drivers testing positive for either cannabis or the combin-
ation of alcohol and cannabis were more likely to be cited
for sign violations, which was not significant for alcohol only
impaired drivers until combined with cannabis (Table 3).
Table 1 Driver and crash characteristics by drug and alcohol use for drivers of passenger vehicles involved in a fatal motor vehicle
crash, Fatality Analysis Reporting System (FARS), 2008–2013 (Continued)
Other 7739 (21.4) 3367 (26.4) 8240 (43.4) 5231 (43.37) 24,577 (30.1)
Collision of vehicle in transport 21,436 (59.4) 6785 (53.1) 5640 (29.7) 3624 (30.1) 37,485 (46.9)
Head-on 2735 (7.6) 865 (6.8) 960 (5.1) 524 (4.3) 5084 (6.4)
Rear-end 6346 (17.6) 2699 (21.1) 2147 (11.3) 1393 (11.6) 12,585 (15.7)
Angle 10,754 (29.8) 2691 (21.1) 2133 (11.2) 1358 (11.3) 16,936 (21.2)
Sideswipe 1417 (3.9) 491 (3.8) 366 (1.9) 322 (2.7) 2596 (3.3)
Other 184 (0.5) 39 (0.3) 34 (0.2) 27 (0.2) 284 (0.4)
Time of the crash 13,520.2 (<0.0001)
Day 22,107 (61.2) 7871 (61.6) 3866 (20.4) 2867 (23.8) 36,711 (45.9)
Night 12,124 (33.6) 4556 (35.6) 14,624 (77.0) 8941 (74.1) 40,245 (50.4)
Weekday/weekend 4382.8 (<0.0001)
Weekday 23,726 (65.7) 8634 (67.7) 8048 (42.4) 5499 (45.6) 45,907 (57.4)
Weekend 11,803 (32.7) 4034 (31.6) 10,807 (56.9) 6499 (53.9) 33,143 (41.5)
Speed 6359.1 (<0.0001)
No 29,138 (80.7) 9222 (72.2) 10,293 (54.21) 6052 (50.2) 54,705 (68.4)
Yes 6409 (27.3) 3200 (25.1) 8196 (43.2) 5708 (47.3) 23,513 (29.4)
Ejection 3921.4 (<0.0001)
Ejected 3956 (11.0) 2105 (16.5) 5669 (29.9) 3564 (29.6) 15,294 (19.1)
Not ejected 32,092 (88.7) 10,628 (83.2) 13,250 (69.8) 8443 (70.0) 64,413 (80.6)
a9.1 % are police reported for alcohol involvement
Table 2 Distribution of moving violations by drug/drug categories for drivers of passenger vehicles involved in a fatal motor vehicle
crash, Fatality Analysis Reporting System (FARS), 2008–2013
Not a moving violation n (%) Any moving violation n (%) Total
No drug or alcohol 22,212 (66.8) 11,047 (33.2) 33,259
Narcotics 1328 (62.5) 798 (37.5) 2126
Depressants 1159 (59.4) 793 (40.6) 1952
Stimulants 907 (53.7) 783 (46.3) 1690
Cannabis 1838 (57.0) 1385 (43.0) 3223
Alcohol 8506 (48.6) 8997 (51.4) 17,503
Cannabis+alcohol 2022 (48.9) 2112 (51.1) 4134
Any Drug 24,415 (52.3) 22,258 (47.7) 46,673
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Fig. 2 a–f Odds ratio with 95 % CI for moving violations by violation type and drug category adjusted for age, gender, time of day, weekend,
number of occupants, FARS 2008–2013. a Total moving violations. b Lane violations. c Passing violations. d Speed-related violations. e Sign
violations. f Turning violations
Table 3 Multivariable adjusted odds ratios with (95 % CI) of driving error/driving violations by drug and drug categories compared
to drivers with no drug and alcohol detecteda
Narcotics Depressants Stimulants Cannabis Alcohol Cannabis + Alcohol Any drug
Driving violations
Any moving violation 1.32 (1.12, 1.46) 1.50 (1.35, 1.66) 1.84 (1.65, 2.05) 1.38 (1.27, 1.49) 2.15 (2.06, 2.24) 2.13 (1.98, 2.28) 1.84 (1.78, 1.91)
Reckless violation 1.38 (1.21, 1.58) 1.79 (1.58, 2.0) 1.52 (1.32, 1.75) 1.55 (1.41, 1.72) 2.29 (2.17, 2.43) 2.37 (2.18, 2.57) 2.10 (2.01, 2.20)
Lane violation 1.36 (1.15, 1.60) 1.41 (1.12, 1.67) 1.48 (1.24, 1.77) 1.48 (1.38, 1.59) 1.50 (1.34, 1.68) 1.47 (1.39, 1.55)
Passing violation 1.42 (1.20, 1.68) 1.64 (1.39, 1.93) 1.65 (1.38, 1.97) 1.76 (1.63, 1.90) 1.50 (1.33, 1.69) 1.50 (1.42, 1.60)
Speed-related violation 2.54 (2.03, 3.17) 1.42 (1.19, 1.69) 1.68 (1.53, 1.85) 2.36 (2.05, 2.71) 1.67 (1.55, 1.81)
Sign violation 1.21 (1.04, 1.39) 1.11 (1.26, 1.44) 1.08 (1.02, 1.15)
Turning violation 1.56 (1.27, 1.93) 1.12 (1.02, 1.24) 0.96 (0.89, 1.03)
aAdjusted for age, gender, time of day, weekend, number of occupants
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Discussion
The major findings of this study indicate that specific
drug classes and drug and alcohol combinations are as-
sociated with different patterns of driving violations
among drivers involved in fatal crashes. This study ex-
tends the work of previous authors by examining and
quantifying behaviors associated with fatal motor vehicle
crashes including restraint use, speeding, passing and
other violations across drug and drug categories (Timby
et al. 1998; Longo et al. 2000).
The prevalence of non-alcohol drug use by drivers has
increased in the last few years with recent studies report-
ing that marijuana has become the leading drug detected
in fatal crashes (Brady and Li 2014). While the association
of alcohol and fatal car crashes has long been recognized,
the legalization of marijuana for both medical and rec-
reational use and the presence of multiple drug combi-
nations could pose increased threats to motor vehicle
occupant safety (Anderson and Rees 2014; Johnson et
al. 2012).
We also found that some categories of drug users tend
to have excessive speed-related crashes, which is incon-
sistent with former studies (Bogstrand et al. 2015), al-
though these studies did not examine speeding by drug/
drug categories. We also found that violations and man-
ner of collision varied by presence of drug and by drug
categories.
While this study is consistent with other work that
demonstrates increased mortality with drugs and alco-
hol, it extends these findings by describing and quantify-
ing driving behaviors and driving violations (Mura et al.
2003; Li et al. 2013; Romano and Pollini 2013; Bédard et
al. 2007). Restraint use also varied by drug and alcohol
status, with the combined use of alcohol and drugs being
associated with lower restraint use. Drivers on stimulants
had the highest odds of being unrestrained, followed by
depressants, narcotics and cannabis.
This study has limitations. First, our findings are based
on drivers involved in fatal crashes who received both al-
cohol and drug tests. Further, drug and alcohol status is
based on drug and alcohol tests, which indicate drugs
detected in the body. It is not known how much the
driver was under the influence of particular drug, particu-
larly for cannabis where detection can last an extended
period of time. While tetrahydrocannabinol (THC) can be
detected several days after consumption of cannabis, other
work in this area has noted that recent use and high doses
of cannabis is a better predictor of crash risks (Ramaekers
et al. 2004). We did not have this information in our data.
The continual introduction of new designer drugs and
substance combinations being developed may have con-
tributed to misclassification through a decreased likeli-
hood of drug detection and also to the presence of some
drugs for which tests were not performed. To the extent
this occurred, it could have resulted in lower odds of driv-
ing violations being associated with drugs. Testing also
varied by several factors including crash time of day, geo-
graphic region and driver injury severity. Drivers who
were fatally injured were more likely to be tested com-
pared to those who were not fatally injured. In addition,
this study used alcohol as a dichotomous variable, which
didn’t control for the dose-effect of alcohol consumption
on levels of impairment (Calhoun et al. 2004; West et al.
1993). However 85 % of drivers had alcohol levels that are
considered legally drunk. Additional limitations of this
study include that driving errors and violations are catego-
rized based on violations charged. Earlier versions of
FARS included additional information in crash-related fac-
tors, which was not available for the years examined in
this study.
Conclusions
In summary, the results of our study indicate that sub-
stance and alcohol use among drivers is associated with
lower restraint use, increased driving violations and driv-
ing errors, and that these violations vary by substance and
substance combinations. Our results also indicate that the
presence of drug and drug and alcohol combinations ex-
acerbate risky behaviors, such as driving unrestrained and
making driving violations typically viewed as being associ-
ated with higher fatality.
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